Screener
Beam Therapeutics BEAM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $288,291 | $294,944 |
| Marketable securities | 923,361 | 950,266 |
| Prepaid expenses and other current assets | 55,301 | 23,478 |
| Total current assets | 1,266,953 | 1,268,688 |
| Property and equipment, net | 101,247 | 104,500 |
| Restricted cash | 6,693 | 6,676 |
| Operating lease right-of-use assets | 98,148 | 100,679 |
| Other assets | 7,757 | 634 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Beam Therapeutics's total current assets?
- Beam Therapeutics (BEAM) reported total current assets of $1.27B in Q1 2026.
- How has Beam Therapeutics's total current assets changed year-over-year?
- Beam Therapeutics's total current assets increased by 1.6% year-over-year, from $1.25B to $1.27B.
- What is the long-term trend for Beam Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Beam Therapeutics's total current assets has grown at a 32.7% compound annual growth rate (CAGR), from $308.32M to $1.27B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Beam Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude